Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma.

Greenberger S, Yuan S, Walsh LA, Boscolo E, Kang KT, Matthews B, Mulliken JB, Bischoff J.

J Invest Dermatol. 2011 Dec;131(12):2467-76. doi: 10.1038/jid.2011.300.

2.

Infantile hemangioma research: looking backward and forward.

Frieden IJ.

J Invest Dermatol. 2011 Dec;131(12):2345-8. doi: 10.1038/jid.2011.315.

3.

Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells.

Huang L, Nakayama H, Klagsbrun M, Mulliken JB, Bischoff J.

Stem Cells. 2015 Jan;33(1):133-45. doi: 10.1002/stem.1841.

4.

Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells.

Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J.

N Engl J Med. 2010 Mar 18;362(11):1005-13. doi: 10.1056/NEJMoa0903036.

5.

Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression.

Greenberger S, Adini I, Boscolo E, Mulliken JB, Bischoff J.

Angiogenesis. 2010 Dec;13(4):327-35. doi: 10.1007/s10456-010-9189-6.

6.

Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.

Munabi NC, England RW, Edwards AK, Kitajewski AA, Tan QK, Weinstein A, Kung JE, Wilcox M, Kitajewski JK, Shawber CJ, Wu JK.

Stem Cells Transl Med. 2016 Jan;5(1):45-55. doi: 10.5966/sctm.2015-0076.

7.

Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells.

Ma X, Zhao T, Ouyang T, Xin S, Ma Y, Chang M.

Int J Clin Exp Pathol. 2014 Jun 15;7(7):3809-17.

8.

Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin.

Du W, Gerald D, Perruzzi CA, Rodriguez-Waitkus P, Enayati L, Krishnan B, Edmonds J, Hochman ML, Lev DC, Phung TL.

Lab Invest. 2013 Oct;93(10):1115-27. doi: 10.1038/labinvest.2013.98.

9.

Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.

Nishi M, Akutsu H, Kudoh A, Kimura H, Yamamoto N, Umezawa A, Lee SW, Ryo A.

Oncotarget. 2014 Sep 30;5(18):8665-80.

10.

Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model.

Xu D, O TM, Shartava A, Fowles TC, Yang J, Fink LM, Ward DC, Mihm MC, Waner M, Ma Y.

J Hematol Oncol. 2011 Dec 22;4:54. doi: 10.1186/1756-8722-4-54.

11.

Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.

Zhang L, Mai HM, Zheng J, Zheng JW, Wang YA, Qin ZP, Li KL.

Int J Clin Exp Pathol. 2013 Dec 15;7(1):48-55.

12.

Characterization of Endothelial Microparticles Induced by Different Therapeutic Drugs for Infantile Hemangioma.

Zhu JY, Zhang W, Ren JG, Chen G, Zhao YF.

J Cardiovasc Pharmacol. 2015 Sep;66(3):261-9. doi: 10.1097/FJC.0000000000000273.

PMID:
26348824
13.

Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.

Khan ZA, Boscolo E, Picard A, Psutka S, Melero-Martin JM, Bartch TC, Mulliken JB, Bischoff J.

J Clin Invest. 2008 Jul;118(7):2592-9. doi: 10.1172/JCI33493.

14.

Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome.

Kaylani S, Theos AJ, Pressey JG.

Pediatr Dermatol. 2013 Nov-Dec;30(6):e194-7. doi: 10.1111/pde.12023.

PMID:
23316753
15.

Pharmacologic therapies for infantile hemangioma: is there a rational basis?

Itinteang T, Withers AH, Leadbitter P, Day DJ, Tan ST.

Plast Reconstr Surg. 2011 Aug;128(2):499-507. doi: 10.1097/PRS.0b013e31821b63a0. Review.

PMID:
21788841
16.

α6-Integrin is required for the adhesion and vasculogenic potential of hemangioma stem cells.

Smadja DM, Guerin CL, Boscolo E, Bieche I, Mulliken JB, Bischoff J.

Stem Cells. 2014 Mar;32(3):684-93. doi: 10.1002/stem.1539.

17.

[Medication-based therapy of infantile hemangioma and lymphatic malformations].

Rössler J, Braunschweiger F, Schill T.

HNO. 2014 Jan;62(1):12-8. doi: 10.1007/s00106-013-2794-0. German.

PMID:
24434958
18.

Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma.

Yang C, Zhang Y, Zhang Y, Zhang Z, Peng J, Li Z, Han L, You Q, Chen X, Rao X, Zhu Y, Liao Z.

Int J Oncol. 2015 Sep;47(3):909-17. doi: 10.3892/ijo.2015.3100.

19.

The embryo-placental CD15-positive "vasculogenic zones" as a source of propranolol-sensitive pediatric vascular tumors.

Seidmann L, Anspach L, Roth W.

Placenta. 2016 Feb;38:93-9. doi: 10.1016/j.placenta.2015.12.013.

PMID:
26907387
20.

Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Greenberger S, Bischoff J.

Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006460. doi: 10.1101/cshperspect.a006460. Review.

Items per page

Supplemental Content

Support Center